[chasil]

Antibody manufacture is not cheap. The antibodies are made by fusing the b-memory cells with mouse cancer, then putting the result in a bioreactor and filtering out the desired product, which must then be refrigerated. Drugs that use this technique commonly end in -MAB (for monoclonal antibody).

[L_Rahman]

Given the entrenched nature of the American pharmaceutical industry, I'm unconvinced that any of them have actually tried to solve the problem of cheap antibody manufacturing at scale.

[refurb]

Why wouldn't they? Any reduction in cost is pure profit for them.

[Kalium]

Reflexive paranoia rather than calm business analysis tends to rule the day when pharmaceutical companies are under consideration.

[danielmorozoff]

Are these monoclonals or polys? Does anyone have a paper ref?